ARCUTIS BIOTHERAPEUTICS INC (ARQT)
US03969K1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ARQT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.36. This target is 105.37% above the current price.
ARQT was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ARQT.
In the previous month the buy percentage consensus was at a similar level.
ARQT was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-02-28 | Mizuho | Reiterate | Buy -> Buy |
| 2024-02-28 | Needham | Maintains | Buy -> Buy |
| 2024-02-28 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-23 | Mizuho | Reiterate | Buy -> Buy |
| 2024-01-03 | Mizuho | Upgrade | Neutral -> Buy |
| 2024-01-02 | Mizuho | Upgrade | Neutral -> Buy |
| 2023-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-08 | JonesTrading | Downgrade | Buy -> Hold |
| 2023-11-06 | Needham | Maintains | Buy -> Buy |
| 2023-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-27 | Mizuho | Downgrade | Buy -> Neutral |
| 2023-10-13 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-09-25 | Mizuho | Reiterate | Buy -> Buy |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-10 | Needham | Reiterate | Buy -> Buy |
| 2023-08-09 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-07-18 | Needham | Reiterate | Buy -> Buy |
| 2023-06-28 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-06-12 | Mizuho | Reiterate | Buy -> Buy |
| 2023-05-26 | Truist Securities | Maintains | Buy -> Buy |
| 2023-05-17 | Needham | Reiterate | Buy -> Buy |
| 2023-05-11 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-05-10 | Mizuho | Maintains | Buy |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-04-19 | Needham | Reiterate | Buy |
| 2023-04-12 | Morgan Stanley | Maintains | Overweight |
| 2023-04-11 | Mizuho | Reiterate | Buy |
| 2023-03-29 | Truist Securities | Maintains | Buy |
| 2023-03-16 | Needham | Maintains | Buy |